These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16732600)

  • 1. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
    Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
    Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
    Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers in thyroid cancer diagnostics.
    Kato MA; Fahey TJ
    Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
    Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
    Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the clinical application of thyroid cancer biomarkers.
    Shibru D; Chung KW; Kebebew E
    Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
    Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
    Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of thyroid cancer: state of art.
    Boufraqech M; Patel D; Xiong Y; Kebebew E
    Expert Opin Med Diagn; 2013 Jul; 7(4):331-42. PubMed ID: 23701167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
    Carpi A; Mechanick JI; Saussez S; Nicolini A
    J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules.
    Gasbarri A; Marchetti C; Iervasi G; Bottoni A; Nicolini A; Bartolazzi A; Carpi A
    Biomed Pharmacother; 2004; 58(6-7):356-9. PubMed ID: 15271416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RESULTS OF RESEARCH OF GALECTIN-3 AND THYROGLOBULIN IN PATIENTS WITH THYROID NODULES].
    Olifirova OS; Knalian SV
    Vestn Khir Im I I Grek; 2015; 174(2):81-3. PubMed ID: 26234070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
    Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
    Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence.
    Hartl DM; Chami L; Al Ghuzlan A; Leboulleux S; Baudin E; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2602-8. PubMed ID: 19551443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
    Layfield LJ; Abrams J; Cochand-Priollet B; Evans D; Gharib H; Greenspan F; Henry M; LiVolsi V; Merino M; Michael CW; Wang H; Wells SA
    Diagn Cytopathol; 2008 Jun; 36(6):442-8. PubMed ID: 18478610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.